Semaglutide/dapagliflozin A 1.5/10 mg clinical trials

A study comparing exposure of semaglutide and dapagliflozin dosed orally as mono-components versus in a fixed-dose combination

This study is looking at two medicines for type 2 diabetes, semaglutide and dapagliflozin. Researchers want to see how well the body uses these medicines when given separately, compared to when they are combined into one single tablet.